Skip to main content
Top
Published in: Pediatric Nephrology 9/2005

01-09-2005 | Letter to the Editors

Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome

Authors: Shuichiro Fujinaga, Kazunari Kaneko, Masaru Takada, Yoshiyuki Ohtomo, Shunji Akashi, Yuichiro Yamashiro

Published in: Pediatric Nephrology | Issue 9/2005

Login to get access

Excerpt

Sirs, …
Literature
1.
go back to reference Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G (2005) Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 20:25–29CrossRefPubMed Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G (2005) Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 20:25–29CrossRefPubMed
2.
go back to reference Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer H, Budde K (2002) Cyclosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proc 34:1738–1739CrossRefPubMed Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer H, Budde K (2002) Cyclosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proc 34:1738–1739CrossRefPubMed
3.
go back to reference Perkovitz MD, Barbeito R for the Simolect US01 Study Group (2002) Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transplant 16:378–382CrossRefPubMed Perkovitz MD, Barbeito R for the Simolect US01 Study Group (2002) Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transplant 16:378–382CrossRefPubMed
4.
go back to reference Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, Sasaki H, Okabayashi J, Murano M, Sakurada T, Imai G, Shirai S, Kuboshima S, Shima Y, Ogimoto G, Sato T, Masuhara K, Kimura K (2005) More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy 25:52–58CrossRefPubMed Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, Sasaki H, Okabayashi J, Murano M, Sakurada T, Imai G, Shirai S, Kuboshima S, Shima Y, Ogimoto G, Sato T, Masuhara K, Kimura K (2005) More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy 25:52–58CrossRefPubMed
5.
go back to reference Kavukc S, Soylu A, Turkmen M, Kasap B, Gumustekin M, Gulay H (2004) Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period. Pediatr Nephrol 19:667–671CrossRefPubMed Kavukc S, Soylu A, Turkmen M, Kasap B, Gumustekin M, Gulay H (2004) Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period. Pediatr Nephrol 19:667–671CrossRefPubMed
6.
go back to reference Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ (1986) Age-dependent cyclosporine pharmacokinetics in marrow transplant recipients. Clin Pharmacol 40:438–443 Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ (1986) Age-dependent cyclosporine pharmacokinetics in marrow transplant recipients. Clin Pharmacol 40:438–443
Metadata
Title
Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome
Authors
Shuichiro Fujinaga
Kazunari Kaneko
Masaru Takada
Yoshiyuki Ohtomo
Shunji Akashi
Yuichiro Yamashiro
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 9/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-005-1932-7

Other articles of this Issue 9/2005

Pediatric Nephrology 9/2005 Go to the issue

Announcements

September 2005